Back to drug safety directory
Anticonvulsant / mood stabilizer (carbamazepine analog)Reviewed May 17, 2026

Oxcarbazepine (Trileptal) and Ketamine Therapy | Tovani Health

Trileptal (Oxcarbazepine) (also: Oxtellar)Anticonvulsant / mood stabilizer (carbamazepine analog)

Verdict at Tovani Health

Compatible; CYP3A4 induction is weaker than carbamazepine but still relevant.

Oxcarbazepine and ketamine are compatible. Oxcarbazepine is a structural analog of carbamazepine designed to have a milder side-effect profile, including milder CYP3A4 induction. The effect on ketamine exposure is real but smaller than carbamazepine's; we plan around it rather than refuse.

If you take Trileptal regularly and are considering at-home ketamine therapy, the combination is safe with monitoring or dose adjustment. This page covers the brief pharmacologic context and what we do at intake.

How Trileptal interacts with ketamine

Oxcarbazepine blocks voltage-gated sodium channels. Weak-to-moderate CYP3A4 inducer (less potent than carbamazepine). Hyponatremia is a notable side effect.

What we do at intake

Disclose dose and indication. Tell us about any recent sodium level checks. Continue as prescribed.

Bottom line

Oxcarbazepine and ketamine are compatible. Oxcarbazepine is a structural analog of carbamazepine designed to have a milder side-effect profile, including milder CYP3A4 induction. The effect on ketamine exposure is real but smaller than carbamazepine's; we plan around it rather than refuse.

Ready to find out if at-home ketamine fits your situation?

We’ll note that you’re on Trileptal (Oxcarbazepine) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.

FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.

Sources

The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.

  1. Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthetic and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Clinical Pharmacokinetics. 2016. PMID: 27028535

Clinically reviewed

Reviewed by Benjamin Soffer, DO on May 17, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.

This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.